HuagongsheHuagongshe Chemistry Print Report · For research reference only
Acridan → N-[4-(Benzothiazol-2-yl)-Phenyl]Acridan
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Acridan | HCID 7106 | — |
| Reactant | Tris(1,1-dimethylethyl)phosphine | HCID 83681 | — |
| Reactant | 2-(4-Bromophenyl)benzothiazole | HCID 2320602 | — |
| Reactant | Sodium t-butoxide | HCID 23676156 | — |
| Catalyst | palladium(II) acetate | HCID 167845 | — |
| Solvent | Toluene | HCID 1140 | — |
| Product | N-[4-(Benzothiazol-2-yl)-Phenyl]Acridan | HCID 69639910 | — |
Reaction Steps
A mixture of 3.74 g of acridan (20 mmol), 69 mg of Pd(OAc)2 (0.3 mmol), 44 mg of tri-t-butylphosphine (0.22 mmol), 2.88 g of sodium t-butoxide (30 mmol), and 6.0 g of 2-(4-bromophenyl)benzothiazole (20 mmol) in 60 mL of toluene was stirred at room temperature for 1 h under inert atmosphere, followed by heating at 50° C. for 1 h. The reaction mixture was cooled to room temperature, filtered and concentrated under reduced pressure. The crude product was purified by column chromatography with 15% ethyl acetate in hexanes. NMR analysis confirmed that 3.1 g of the N-arylated acridan product was isolated.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06410732B2 |
| Source dataset | uspto-grants-2002_06 |
| ORD ID | ord-f11c4018188149389bde5934550c33e3 |
| Source note | uspto-grants-2002_06 |